XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,675,988 | -11.3% | 751,639 | 0.0% | 0.15% | -11.4% |
| Q2 2023 | $28,938,102 | +7.6% | 751,639 | 0.0% | 0.17% | +14.4% |
| Q1 2023 | $26,901,160 | -9.2% | 751,639 | 0.0% | 0.15% | -18.0% |
| Q4 2022 | $29,637,126 | +9.2% | 751,639 | 0.0% | 0.18% | 0.0% |
| Q3 2022 | $27,134,000 | +18.7% | 751,639 | 0.0% | 0.18% | +36.9% |
| Q2 2022 | $22,865,000 | -0.5% | 751,639 | 0.0% | 0.13% | -1.5% |
| Q1 2022 | $22,978,000 | -2.1% | 751,639 | 0.0% | 0.13% | +15.8% |
| Q4 2021 | $23,481,000 | +104.4% | 751,639 | 0.0% | 0.11% | +128.0% |
| Q3 2021 | $11,485,000 | -17.9% | 751,639 | 0.0% | 0.05% | -18.0% |
| Q2 2021 | $13,996,000 | +4.0% | 751,639 | 0.0% | 0.06% | +5.2% |
| Q1 2021 | $13,454,000 | +27.3% | 751,639 | +9.3% | 0.06% | +45.0% |
| Q4 2020 | $10,572,000 | +25.6% | 687,386 | -9.6% | 0.04% | +17.6% |
| Q3 2020 | $8,417,000 | -16.0% | 760,308 | -4.9% | 0.03% | -22.7% |
| Q2 2020 | $10,021,000 | – | 799,102 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |